Latest Potassium-sparing diuretics Stories
A large study addressing the effectiveness and safety of aldosterone antagonist therapy for older heart failure patients has found notable differences between the drug's results in clinical trial vs. what occurs in actual practice.
A study published in JAMA on October 21 by Nancy M. Albert and colleagues, exploring aldosterone antagonist usage among US patients hospitalized with heart failure, found that only one-third of patients meeting current US Clinical Practice Guidelines criteria were actually being treated.
Less than one-third of heart failure patients leave the hospital with drugs recommended for their condition, researchers reported Tuesday.
Patients with high blood pressure who took a diuretic and a potassium-sparing drug, reduced cardiac mortality by 40 percent, U.S. researchers said. The current U.S.
Two inexpensive but widely overlooked drugs may help many patients who continue to have high blood pressure despite taking standard blood pressure medications, according to research by Indiana University School of Medicine scientists.